(2R)-3-cyclobutyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]propanoic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(2S)-2-methyl-3-phenylpropyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-pyrazin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-quinoxalin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid

C169H233F2N17O10 — CID 161347916

IUPAC(2R)-3-cyclobutyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]propanoic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(2S)-2-methyl-3-phenylpropyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-pyrazin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-quinoxalin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid
SMILESCCc1nc2c(C)cc(C)nc2n1CCCC1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1.C[C@H](Cc1ccccc1)CC1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1.O=C(O)C(CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(F)c(F)c3)CC2)[C@@H](c2ccccc2)C1.O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCc3cnc4ccccc4n3)CC2)[C@@H](c2ccccc2)C1.O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCc3cnccn3)CC2)[C@@H](c2ccccc2)C1
InChIInChI=1S/C37H53N5O2.C35H46N4O2.C34H48N2O2.C32H42F2N2O2.C31H44N4O2/c1-4-33-39-34-26(2)22-27(3)38-36(34)42(33)19-11-12-28-17-20-40(21-18-28)23-31-24-41(25-32(31)29-13-7-5-8-14-29)35(37(43)44)30-15-9-6-10-16-30;40-35(41)34(28-13-5-2-6-14-28)39-24-29(31(25-39)27-11-3-1-4-12-27)23-38-20-18-26(19-21-38)10-9-15-30-22-36-32-16-7-8-17-33(32)37-30;1-26(21-27-11-5-2-6-12-27)22-28-17-19-35(20-18-28)23-31-24-36(25-32(31)29-13-7-3-8-14-29)33(34(37)38)30-15-9-4-10-16-30;33-29-13-12-25(18-30(29)34)9-4-6-23-14-16-35(17-15-23)20-27-21-36(22-28(27)26-10-2-1-3-11-26)31(32(37)38)19-24-7-5-8-24;36-31(37)30(26-11-5-2-6-12-26)35-22-27(29(23-35)25-9-3-1-4-10-25)21-34-18-14-24(15-19-34)8-7-13-28-20-32-16-17-33-28/h5,7-8,13-14,22,28,30-32,35H,4,6,9-12,15-21,23-25H2,1-3H3,(H,43,44);1,3-4,7-8,11-12,16-17,22,26,28-29,31,34H,2,5-6,9-10,13-15,18-21,23-25H2,(H,40,41);2-3,5-8,11-14,26,28,30-33H,4,9-10,15-25H2,1H3,(H,37,38);1-3,10-13,18,23-24,27-28,31H,4-9,14-17,19-22H2,(H,37,38);1,3-4,9-10,16-17,20,24,26-27,29-30H,2,5-8,11-15,18-19,21-23H2,(H,36,37)/t31-,32+,35+;29-,31+,34+;26-,31+,32-,33-;27-,28+,31?;27-,29+,30+/m00100/s1
InChIKeyVNNZCWIDLVMODS-BTBUKJCISA-N
MW2700.83 g/mol
LogP31.60
Rot. Bonds52

About (2R)-3-cyclobutyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]propanoic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(2S)-2-methyl-3-phenylpropyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-pyrazin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-quinoxalin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid

(2R)-3-cyclobutyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]propanoic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(2S)-2-methyl-3-phenylpropyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-pyrazin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-quinoxalin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid (PubChem CID 161347916) has the molecular formula C169H233F2N17O10 and a molecular weight of 2700.83 g/mol. Its IUPAC name is (2R)-3-cyclobutyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]propanoic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(2S)-2-methyl-3-phenylpropyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-pyrazin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-quinoxalin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid.

Molecular Properties

Compound Name(2R)-3-cyclobutyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]propanoic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(2S)-2-methyl-3-phenylpropyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-pyrazin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-quinoxalin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid
PubChem CID161347916
Molecular FormulaC169H233F2N17O10
Molecular Weight2700.83 g/mol
Exact Mass2698.82
IUPAC Name(2R)-3-cyclobutyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]propanoic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(2S)-2-methyl-3-phenylpropyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-pyrazin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-quinoxalin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid
SMILESCCc1nc2c(C)cc(C)nc2n1CCCC1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1.C[C@H](Cc1ccccc1)CC1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1.O=C(O)C(CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(F)c(F)c3)CC2)[C@@H](c2ccccc2)C1.O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCc3cnc4ccccc4n3)CC2)[C@@H](c2ccccc2)C1.O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCc3cnccn3)CC2)[C@@H](c2ccccc2)C1
InChIInChI=1S/C37H53N5O2.C35H46N4O2.C34H48N2O2.C32H42F2N2O2.C31H44N4O2/c1-4-33-39-34-26(2)22-27(3)38-36(34)42(33)19-11-12-28-17-20-40(21-18-28)23-31-24-41(25-32(31)29-13-7-5-8-14-29)35(37(43)44)30-15-9-6-10-16-30;40-35(41)34(28-13-5-2-6-14-28)39-24-29(31(25-39)27-11-3-1-4-12-27)23-38-20-18-26(19-21-38)10-9-15-30-22-36-32-16-7-8-17-33(32)37-30;1-26(21-27-11-5-2-6-12-27)22-28-17-19-35(20-18-28)23-31-24-36(25-32(31)29-13-7-3-8-14-29)33(34(37)38)30-15-9-4-10-16-30;33-29-13-12-25(18-30(29)34)9-4-6-23-14-16-35(17-15-23)20-27-21-36(22-28(27)26-10-2-1-3-11-26)31(32(37)38)19-24-7-5-8-24;36-31(37)30(26-11-5-2-6-12-26)35-22-27(29(23-35)25-9-3-1-4-10-25)21-34-18-14-24(15-19-34)8-7-13-28-20-32-16-17-33-28/h5,7-8,13-14,22,28,30-32,35H,4,6,9-12,15-21,23-25H2,1-3H3,(H,43,44);1,3-4,7-8,11-12,16-17,22,26,28-29,31,34H,2,5-6,9-10,13-15,18-21,23-25H2,(H,40,41);2-3,5-8,11-14,26,28,30-33H,4,9-10,15-25H2,1H3,(H,37,38);1-3,10-13,18,23-24,27-28,31H,4-9,14-17,19-22H2,(H,37,38);1,3-4,9-10,16-17,20,24,26-27,29-30H,2,5-8,11-15,18-19,21-23H2,(H,36,37)/t31-,32+,35+;29-,31+,34+;26-,31+,32-,33-;27-,28+,31?;27-,29+,30+/m00100/s1
InChIKeyVNNZCWIDLVMODS-BTBUKJCISA-N
XLogP31.60
TPSA301.17 Ų
H-Bond Donors5
H-Bond Acceptors22
Rotatable Bonds52
Heavy Atoms198
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002700.83
LogP ≤ 531.60
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1022

Analyze (2R)-3-cyclobutyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]propanoic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(2S)-2-methyl-3-phenylpropyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-pyrazin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-quinoxalin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-3-cyclobutyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]propanoic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(2S)-2-methyl-3-phenylpropyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-pyrazin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-quinoxalin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid?
The IUPAC name of (2R)-3-cyclobutyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]propanoic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(2S)-2-methyl-3-phenylpropyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-pyrazin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-quinoxalin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid (CID 161347916) is (2R)-3-cyclobutyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]propanoic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(2S)-2-methyl-3-phenylpropyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-pyrazin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-quinoxalin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid.
What is the SMILES notation for (2R)-3-cyclobutyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]propanoic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(2S)-2-methyl-3-phenylpropyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-pyrazin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-quinoxalin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid?
The canonical SMILES for (2R)-3-cyclobutyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]propanoic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(2S)-2-methyl-3-phenylpropyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-pyrazin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-quinoxalin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid is CCc1nc2c(C)cc(C)nc2n1CCCC1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1.C[C@H](Cc1ccccc1)CC1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1.O=C(O)C(CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(F)c(F)c3)CC2)[C@@H](c2ccccc2)C1.O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCc3cnc4ccccc4n3)CC2)[C@@H](c2ccccc2)C1.O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCc3cnccn3)CC2)[C@@H](c2ccccc2)C1.
What is the InChIKey of (2R)-3-cyclobutyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]propanoic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(2S)-2-methyl-3-phenylpropyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-pyrazin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-quinoxalin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid?
The InChIKey is VNNZCWIDLVMODS-BTBUKJCISA-N. The full InChI is InChI=1S/C37H53N5O2.C35H46N4O2.C34H48N2O2.C32H42F2N2O2.C31H44N4O2/c1-4-33-39-34-26(2)22-27(3)38-36(34)42(33)19-11-12-28-17-20-40(21-18-28)23-31-24-41(25-32(31)29-13-7-5-8-14-29)35(37(43)44)30-15-9-6-10-16-30;40-35(41)34(28-13-5-2-6-14-28)39-24-29(31(25-39)27-11-3-1-4-12-27)23-38-20-18-26(19-21-38)10-9-15-30-22-36-32-16-7-8-17-33(32)37-30;1-26(21-27-11-5-2-6-12-27)22-28-17-19-35(20-18-28)23-31-24-36(25-32(31)29-13-7-3-8-14-29)33(34(37)38)30-15-9-4-10-16-30;33-29-13-12-25(18-30(29)34)9-4-6-23-14-16-35(17-15-23)20-27-21-36(22-28(27)26-10-2-1-3-11-26)31(32(37)38)19-24-7-5-8-24;36-31(37)30(26-11-5-2-6-12-26)35-22-27(29(23-35)25-9-3-1-4-10-25)21-34-18-14-24(15-19-34)8-7-13-28-20-32-16-17-33-28/h5,7-8,13-14,22,28,30-32,35H,4,6,9-12,15-21,23-25H2,1-3H3,(H,43,44);1,3-4,7-8,11-12,16-17,22,26,28-29,31,34H,2,5-6,9-10,13-15,18-21,23-25H2,(H,40,41);2-3,5-8,11-14,26,28,30-33H,4,9-10,15-25H2,1H3,(H,37,38);1-3,10-13,18,23-24,27-28,31H,4-9,14-17,19-22H2,(H,37,38);1,3-4,9-10,16-17,20,24,26-27,29-30H,2,5-8,11-15,18-19,21-23H2,(H,36,37)/t31-,32+,35+;29-,31+,34+;26-,31+,32-,33-;27-,28+,31?;27-,29+,30+/m00100/s1.
What are the key properties of (2R)-3-cyclobutyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]propanoic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(2S)-2-methyl-3-phenylpropyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-pyrazin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-quinoxalin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid?
(2R)-3-cyclobutyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]propanoic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(2S)-2-methyl-3-phenylpropyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-pyrazin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-quinoxalin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid has a molecular weight of 2700.83 g/mol, XLogP of 31.60, 52 rotatable bonds, 5 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-3-cyclobutyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]propanoic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(2S)-2-methyl-3-phenylpropyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-pyrazin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-quinoxalin-2-ylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid is sourced from PubChem (CID 161347916), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).